Tuberculosis in renal transplant recipients on various immunosuppressive regimens

Nephrology Dialysis Transplantation

Volumn 20, Issue 4, 2005, Pages 797-802

  Atasever, Alev ^a   Bacakoglu, Feza ^a   Toz, Huseyin ^a   Basoglu, Ozen Kacmaz ^a   Duman, Soner ^a   Basak, Kemal ^b   Guzelant, Asuman ^c   Sayiner, Abdullah ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Department of Pediatrics   (Turkey)

^c Konak Health District   (Turkey)

Author keywords

Mycophenolate mofetil; Renal transplantation; Tacrolimus; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; ETHAMBUTOL; ISONIAZID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; BACTEREMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG BIOPSY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY;

ADULT; AZATHIOPRINE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PREDNISOLONE; RETROSPECTIVE STUDIES; TACROLIMUS; TUBERCULOSIS;

EID: 17144407278     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh691     Document Type: Review

References (20)

1. Laskow DA, Neylan JF, Shapiro RS, Pirsch JD, Vergne-Marini PJ, Tomlanovich SJ. The role of tacrolimus in adult kidney transplantation: a review. Clin Transplant 1998; 12: 489-503
2. Vella JP, Sayegh MH. Maintenance pharmacological immunosuppressive strategies in renal transplantation. Postgrad Med J 1997; 73: 386-390
3. Jain A, Kashyap R, Dodson F et al. A prospective trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolat mofetil in primary adult liver transplantation: a single center report. Transplantation 2001; 27: 1091-1097
4. Treede H, Klepetko W, Reichhenspurner H et al. Munich and Vienna Lung Transplant Group. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomised two-center trial comparing two different immunosuppressive protocols. J Heart Lung Transplant 2001; 20: 511-517
5. Merion RM, Henry ML, Meizer JS, Sollinger HW, Sutherland DE, Taylor RJ. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. Transplantation 2000; 70: 105-111
6. Waiser J, Schotsel R, Budde K, Neumayer HH. Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation. Am J Kidney Dis 2000; 35: E12
7. John GT, Shankar V. Mycobacterial infections in organ transplant recipients. Semin Respir Infect 2002; 17: 274-283
8. Harisinghani MG, Mcloud TC, Shepard JA et al. Tuberculosis from head to toe. Radiographics 2000; 20: 449-470
9. Sayiner A, Ece T, Duman S et al. Tuberculosis in renal transplant recipients. Transplantation 1999; 68: 1268-1271
10. Tokat Y, Kilic M, Kursat S et al. Tuberculosis after renal transplantation. Transplant Proc 1996; 28: 2353-2354
11. Cavusoglu C, Cicek-Saydam C, Karasu Z et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid organ transplant recipients. Clin Transplant 2002; 16: 257-261
12. Samhan M, Panjawani DD, Dadah SK, Kumar MSA, Araj G, Abouna GM. Is tuberculosis is a contraindication for renal transplantation? Transplant Proc 1989; 21: 2036-2038
13. Delaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc 1993; 25: 2288-2289
14. John GT, Viswanathan S, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60: 1148-1153
15. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423-428
16. Peraira JR, Segovia J, Arroyo R et al. High incidence of severe infections in heart transplant recipients receiving tacrolimus. Transplant Proc 2003; 35: 1999-2000
17. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185
18. Lattes R, Radisic M, Rial M, Argento J, Casadei D. Tuberculosis in renal transplant recipients. Transplant Infect Dis 1999; 1: 98-104
19. Cheshsu RY, Loong CC, Chou MH, Lin MF, Yang WC. Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Ann Pharmacother 2000; 34: 27-31
20. Apaydin S, Altiparmak MR, Serdengecti K, Ataman R, Ozturk R, Erek E. Mycobacterium tuberculosis infections after renal transplantation. Scand J Infect Dis 2000; 32: 501-505